Life Science REIT (LABS) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
News, reports & tips
-
Life Science REIT inks big lease at Oxford Technology Park
13 February 2024 07:29
(Sharecast News) - Life Science REIT announced the full occupancy of building five at Oxford Technology Park (OTP) on Tuesday, encompassing 57,000 square feet, by technology and engineering services provider...
-
Life Science REIT inks letting at Oxford Technology Park
4 January 2024 12:54
(Sharecast News) - Life Science REIT announced a significant letting of 5,551 square feet of space at the Innovation Quarter (IQ) on Thursday, located within Oxford Technology Park (OTP).
-
Life Science REIT agrees to new lease at Oxford Technology Park
27 February 2023 11:03
(Sharecast News) - Real estate investment trust Life Science REIT has agreed to a new lease at its Oxford Technology Park with innovative healthcare technology company Arcturis.
-
Life Science REIT set to move shares to main market
3 November 2022 11:06
(Sharecast News) - Life Science REIT announced on Thursday that, in accordance with the intention it expressed at its initial public offering on AIM, it had decided to apply for its existing shares to be...
-
Life Science REIT confident after first full interim results
22 September 2022 11:00
(Sharecast News) - Life Science REIT said in its first-half results on Thursday that its initial public offering proceeds were now fully invested, in line with its plan to deploy the net proceeds within six...
-
Life Science REIT completes second drawdown on HSBC facility
23 August 2022 09:56
(Sharecast News) - Life Science REIT has completed a second drawdown from its existing £150m debt facility with HSBC, it announced on Tuesday, totalling £37.2m.
-
Life Science REIT pleased with performance since IPO
23 May 2022 11:48
(Sharecast News) - Life Science REIT reported a portfolio value of £192.2m at the end of 2021 in its results on Monday, including a revaluation gain of £14.5m.
-
Life Science REIT pays £120m for Oxford Technology Park
16 May 2022 13:25
(Sharecast News) - Life Science REIT has acquired Oxford Technology Park (OTP), it announced on Monday, for £120.3m.
-
Life Science REIT acquires building in London's Knowledge Quarter
9 May 2022 09:07
(Sharecast News) - Real estate investment trust Life Science has acquired 7-11 Herbrand Street, an iconic Art Deco building close to University College Hospital and University College London in the...
-
Life Science REIT agrees £150m debt financing facility
30 March 2022 09:29
(Sharecast News) - Life Science REIT has agreed a £150m debt financing facility with HSBC UK, it announced on Wednesday, consisting of a £75m three-year term loan, and an equally-sized revolving credit...
-
Life Science acquires freehold to another three buildings at Cambourne Business Park
20 December 2021 09:32
(Sharecast News) - Real estate investment trust Life Science has acquired the freehold to a further three buildings at Cambourne Business Park near Cambridge from Coal Pension Properties for £50.1m,...
-
Life Science acquires freehold to another three buildings at Cambourne Business Park
20 December 2021 09:32
(Sharecast News) - Real estate investment trust Life Science has acquired the freehold to a further three buildings at Cambourne Business Park near Cambridge from Coal Pension Properties for £50.1m,...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.